TERAZOSIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Terazosin, and when can generic versions of Terazosin launch?
Terazosin is a drug marketed by Ajanta Pharma Ltd, Bionpharma, Heritage Pharma Avet, Hikma, Jubilant Cadista, Pharmobedient, Ranbaxy Labs Ltd, Senores Pharms, Chartwell Rx, Ivax Sub Teva Pharms, Sandoz, and Teva. and is included in thirteen NDAs.
The generic ingredient in TERAZOSIN is terazosin hydrochloride. There are twenty-four drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the terazosin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Terazosin
A generic version of TERAZOSIN was approved as terazosin hydrochloride by SENORES PHARMS on March 30th, 1998.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TERAZOSIN?
- What are the global sales for TERAZOSIN?
- What is Average Wholesale Price for TERAZOSIN?
Summary for TERAZOSIN
| US Patents: | 0 |
| Applicants: | 12 |
| NDAs: | 13 |
| Drug Prices: | Drug price information for TERAZOSIN |
| Drug Sales Revenues: | Drug sales revenues for TERAZOSIN |
| DailyMed Link: | TERAZOSIN at DailyMed |
US Patents and Regulatory Information for TERAZOSIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ivax Sub Teva Pharms | TERAZOSIN HYDROCHLORIDE | terazosin hydrochloride | TABLET;ORAL | 074530-001 | Apr 21, 2000 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ranbaxy Labs Ltd | TERAZOSIN HYDROCHLORIDE | terazosin hydrochloride | CAPSULE;ORAL | 076021-004 | Aug 22, 2002 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva | TERAZOSIN HYDROCHLORIDE | terazosin hydrochloride | TABLET;ORAL | 074446-001 | May 18, 2000 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
